德视佳(01846)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01846 德视佳

休市中 09-04 11:10:10

2.350

-0.010

-0.42%

最高2.345	最低2.340	成交量1.00万
今开2.345	昨收2.360	日振幅0.21%
总市值7.54亿	流通市值7.54亿	总股本3.21亿
成交额2.34万	换手率0.00%	流通股本3.21亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01846","market":"HK","secType":"STK","nameCN":"德视佳","latestPrice":2.35,"timestamp":1788491410532,"preClose":2.36,"halted":0,"volume":10000,"delay":0,"changeRate":-0.00423728813559313,"floatShares":321000000,"shares":321000000,"eps":0.17026,"marketStatus":"休市中","change":-0.01,"latestTime":"09-04 11:10:10","open":2.345,"high":2.345,"low":2.34,"amount":23405,"amplitude":0.002119,"askPrice":2.495,"askSize":10000,"bidPrice":2.35,"bidSize":20000,"shortable":0,"etf":0,"ttmEps":0.007789,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788744600000},"marketStatusCode":7,"adr":0,"listingDate":1571068800000,"exchange":"SEHK","adjPreClose":2.36,"dividendRate":0.018766,"openAndCloseTimeList":[[1788485400000,1788494400000],[1788498000000,1788508800000]],"volumeRatio":0.35461,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01846","defaultTab":"news","newsList":[{"id":"1196299771","title":"德视佳2026年8月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1196299771","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196299771?lang=zh_cn&edition=full","pubTime":"2026-09-01 17:00","pubTimestamp":1788253245,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司（股票代码：01846）于2026年9月1日披露8月股份变动月报表，报告期为截至2026年8月31日。\n月报显示，德视佳国际眼科有限公司在报告期内的法定股本为10,000,000美元，注册股本为1,000,000,000股，总面值为每股0.01美元。截至8月末，公司已发行股份合计320,706,000股，与上月末持平，未有新增发行、购回或注销，以及库藏股变动活动。\n公司确认已满足香港联交所相关上市规则所要求的适用公众持股量，并将继续遵守所有适用法律法规与监管规定。公告由公司秘书何家穎签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663003470","title":"德视佳(01846)发布中期业绩，股东应占亏损1356.1万港元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2663003470","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663003470?lang=zh_cn&edition=full","pubTime":"2026-08-31 20:39","pubTimestamp":1788179974,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德视佳(01846)发布截至2026年6月30日止6个月的中期业绩，该集团取得收益4.54亿港元，同比增加20.5%;本公司拥有人应占亏损1356.1万港元，同比盈转亏;每股亏损4.254港仙。公告称，老花眼矫正治疗的显著扩展及纳入瑞士业务为推动收益增长的主要因素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489800.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146138959","title":"德视佳2026年上半年营收4.54亿港元，经调整净利润3,801万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1146138959","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146138959?lang=zh_cn&edition=full","pubTime":"2026-08-31 20:36","pubTimestamp":1788179785,"startTime":"0","endTime":"0","summary":"德视佳披露的最新财报显示，截至2026年6月30日止六个月，公司实现营收4.54亿港元，同比增长20.5%；经调整净利润3,801万元，同比微降约1%。报告期内，毛利率为39.4%，较上年同期下降2.2个百分点；公司经营利润约7,914万元，同比下降40.0%，经营利润率17.4%。经营活动所得现金流为9,102万元，同比下降约10.4%。成本方面，报告期内公司销售费用与管理费用增幅较快，销售费用率约为11.9%，上年同期为11.1%。丹麦市场受局部竞争加剧影响，营收0.34亿港元，下降16.9%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"德视佳2026年上半年营收4.54亿港元，经调整净利润3,801万元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130784161","title":"德视佳国际眼科预警：中期亏损最高或达1700万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130784161","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130784161?lang=zh_cn&edition=full","pubTime":"2026-08-25 00:10","pubTimestamp":1787587844,"startTime":"0","endTime":"0","summary":"德视佳国际眼科诊所有限公司于8月24日发布业绩预警，揭示公司2026年上半年或将面临股东应占亏损。根据公告，预计亏损区间为1000万至1700万港元。德视佳国际眼科诊所作为专注于眼科医疗服务的企业，其业绩表现往往受到手术量、客单价以及运营成本等多重因素的共同影响。投资者在解读这一消息时，不妨将营收增长的积极信号与亏损预警的谨慎信号并重考量，以全面评估公司的中期表现及未来走势。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1219","01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186049304","title":"德视佳（01846）发布盈利预警：2026年上半年预亏1000万至1700万港元 收入预计增至最高4.6亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1186049304","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186049304?lang=zh_cn&edition=full","pubTime":"2026-08-24 22:10","pubTimestamp":1787580629,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司8月24日公告称，根据对集团截至2026年6月30日止六个月未经审计综合管理账目的初步评估，公司预计录得本公司拥有人应占亏损约10百万元至17百万元，而2025年同期则录得溢利约38.4百万元。尽管出现亏损，德视佳预计本期收入约为450百万元至460百万元，较2025年同期的377.1百万元增长约19%至22%。德视佳计划于2026年8月底公布正式中期业绩公告，并提醒投资者审慎决策。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661118274","title":"德视佳(01846)发盈警，预期中期股东应占亏损1000万港元至1700万港元 同比由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2661118274","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661118274?lang=zh_cn&edition=full","pubTime":"2026-08-24 22:06","pubTimestamp":1787580369,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德视佳(01846)发布公告，本集团于2026年中期期间预计将取得本公司拥有人应占亏损1000万港元至1700万港元，而2025年同期则取得本公司拥有人应占溢利约3840万港元。公告称，与2025年同期相比，预期由盈转亏，主要归因于：与收购FYEO Europe B.V.(该交易已于2026年7月22日完成)直接相关的非经常性成本，主要包括就该交易而产生的顾问及专业费用;及本集团的瑞士业务于2025年10月13 日完成瑞士收购事项后，以及在持续进行策略转型期间所产生的经营亏损。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484602.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"德视佳(01846)发盈警，预期中期股东应占亏损1000万港元至1700万港元 同比由盈转亏","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126649431","title":"德视佳预计2026年上半年股东应占亏损1000万至1700万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126649431","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126649431?lang=zh_cn&edition=full","pubTime":"2026-08-24 22:02","pubTimestamp":1787580129,"startTime":"0","endTime":"0","summary":"德视佳国际眼科诊所发布公告，预期截至2026年6月30日止六个月将录得股东应占亏损，金额介于1000万至1700万港元之间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1219","01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192067342","title":"德视佳（01846）拟于8月31日召开董事会审议2026年中期业绩及分红事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1192067342","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192067342?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:10","pubTimestamp":1786698642,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司（01846）8月14日公告称，公司董事会拟于2026年8月31日（星期一）召开会议，主要议程包括：  \n1. 审阅并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩及其刊发；  \n2. 考虑建议派付中期股息（如适用）；  \n3. 处理其他相关事宜。\n公司强调，公告内容的准确性与完整性由公司负责，香港交易及结算所有限公司及香港联合交易所有限公司对其概不负责。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191679753","title":"德视佳（01846）调整董事会及委员会架构","url":"https://stock-news.laohu8.com/highlight/detail?id=1191679753","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1191679753?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:57","pubTimestamp":1785751057,"startTime":"0","endTime":"0","summary":"2026年8月3日，德视佳国际眼科有限公司公告，自同日起，公司董事会及其下设三个专门委员会成员构成如下：。截至公告发布日，上述董事会及委员会调整已正式生效。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154592673","title":"德视佳(01846)任命Rens Laurentius Michaël Schoenmakers为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=1154592673","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154592673?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:53","pubTimestamp":1785750789,"startTime":"0","endTime":"0","summary":"2026年8月3日，德视佳国际眼科有限公司公告称，自2026年8月3日起，Rens Laurentius Michal Schoenmakers先生正式出任公司执行董事，任期两年。董事会对其加入表示欢迎。Schoenmakers先生现年60岁，在欧洲、北美及亚洲的医疗器械、医疗科技及医疗保健行业累积超过20年的首席执行官及董事总经理经验。公司表示，Schoenmakers先生将持续负责欧洲市场业务发展，并在下一届股东周年大会上依公司章程轮值退任并可重选连任。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656327958","title":"德视佳(01846)：Rens Laurentius Michaël Schoenmakers获委任为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2656327958","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656327958?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:47","pubTimestamp":1785750447,"startTime":"0","endTime":"0","summary":"智通财经APP讯，德视佳(01846)发布公告，自2026年8月3日起，Rens Laurentius Michaël Schoenmakers先生，60岁，已获委任为执行董事。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475314.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"德视佳(01846)：Rens Laurentius Michaël Schoenmakers获委任为执行董事","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186222124","title":"德视佳国际眼科诊所：任命Rens Laurentius Michaël Schoenmakers为执行董事，自2026年8月3日起生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1186222124","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1186222124?lang=zh_cn&edition=full","pubTime":"2026-08-03 17:47","pubTimestamp":1785750429,"startTime":"0","endTime":"0","summary":"德视佳国际眼科诊所（EUROEYES）正式宣布，已任命Rens Laurentius Michaël Schoenmakers为执行董事。此项任命将于2026年8月3日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169965051","title":"德视佳更新2026年7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1169965051","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169965051?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:41","pubTimestamp":1785746491,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司于2026年8月3日发布截至2026年7月31日止月份的证券变动月报表，显示公司在报告期内股本状况保持稳定。根据公告披露，德视佳国际眼科有限公司截至2026年7月31日的注册股本为10,000,000美元，折合1,000,000,000股普通股，每股面值0.01美元，与上月底相比无变化。公司月末已发行股份数量为320,706,000股，无库存股份，也未有股份增发、购回及注销活动。本月报表由公司秘书何家颖签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653979176","title":"德视佳(01846.HK)完成)完成收购荷兰眼科","url":"https://stock-news.laohu8.com/highlight/detail?id=2653979176","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653979176?lang=zh_cn&edition=full","pubTime":"2026-07-23 06:58","pubTimestamp":1784761109,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1219","01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116686635","title":"德视佳（01846）7月22日完成1.31亿欧元荷兰眼科集团收购 并调拨2.17亿港元募资加码欧洲布局","url":"https://stock-news.laohu8.com/highlight/detail?id=1116686635","media":"公告速递","labels":["corporation","merge","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116686635?lang=zh_cn&edition=full","pubTime":"2026-07-23 06:50","pubTimestamp":1784760641,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司7月22日公告，公司已于当日收市后完成对目标公司EuroEyes Netherlands的收购及相关增资事项，交易被界定为「非常重大收购事项及关连交易」。上述代价由德视佳承担1.18625267亿欧元，Manco承担1.2725亿欧元，资金来源严格按照此前通函披露的顺序及优先次序支付。认购事项完成后，德视佳对EuroEyes Netherlands的总投资额为1.18625267亿欧元；参与者对认购股份的总出资为1.2725亿欧元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122758959","title":"德视佳特别股东大会全票通过四项普通决议","url":"https://stock-news.laohu8.com/highlight/detail?id=1122758959","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122758959?lang=zh_cn&edition=full","pubTime":"2026-07-17 18:02","pubTimestamp":1784282531,"startTime":"0","endTime":"0","summary":"德视佳2026年7月17日公布，于当日举行的股东特别大会就四项普通决议进行表决，全部获高票通过。\\n\\n公告显示，出席会议并行使投票权的股份共计189,287,952股，占公司已发行股份总数320,706,000股的59.03%。\\n\\n— 第1项决议获189,287,952票赞成，赞成率100%，无反对票。\\n\\n公司称，由于上述各项决议的赞成票数均超过50%，全部以普通决议案获正式通过。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134319140","title":"德视佳更新6月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1134319140","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134319140?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:36","pubTimestamp":1782984972,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司于2026年7月2日发布2026年6月股份变动月报表，报告期截至2026年6月30日。根据公告披露，报告期内公司股本结构及股份数量未发生变化。根据公告，德视佳国际眼科有限公司的注册股本为1,000,000,000股，面值每股0.01美元，对应注册股本总额为10,000,000美元；截至2026年6月30日，公司普通股已发行股份和注册股本均保持稳定，分别为320,706,000股和10,000,000美元，未发生新增发行、购回或注销，也未出现库藏股变动。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166236586","title":"德视佳(01846)7月17日召开股东特别大会　审议收购目标公司及向Manco增资约2,065万欧元","url":"https://stock-news.laohu8.com/highlight/detail?id=1166236586","media":"公告速递","labels":["merge","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1166236586?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:56","pubTimestamp":1782824164,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司公告，将于2026年7月17日16:00在香港夏悫道18号海富中心1座24楼召开股东特别大会，拟表决四项普通决议：","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643750955","title":"德视佳(01846)：EuroEyes Netherlands拟向Manco发行认购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2643750955","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643750955?lang=zh_cn&edition=full","pubTime":"2026-06-16 21:15","pubTimestamp":1781615724,"startTime":"0","endTime":"0","summary":"根据认购协议，管理层已同意将彼自收购事项所获的部分所得款项再投资于EuroEyes Netherlands的股本内。待收购事项完成及认购事项完成后，EuroEyes Netherlands将继续为本公司的附属公司。在根据认购协议完成认购事项之日或前后，本公司、EuroEyes Netherlands、Manco及 STAK将就股本订立股东协议，并据此规范EuroEyes Netherlands的管理。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","01846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151051661","title":"德视佳荷兰子公司与Fyeo Manco达成认购股份协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1151051661","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151051661?lang=zh_cn&edition=full","pubTime":"2026-06-16 21:02","pubTimestamp":1781614965,"startTime":"0","endTime":"0","summary":"德视佳国际眼科有限公司宣布，其荷兰子公司Euroeyes Netherlands已与Fyeo Manco达成协议，将向后者发行认购股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1219","01846"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.euroeyes.hk","stockEarnings":[{"period":"1week","weight":-0.0084},{"period":"1month","weight":-0.06},{"period":"3month","weight":-0.0916},{"period":"6month","weight":-0.2177},{"period":"1year","weight":-0.218},{"period":"ytd","weight":-0.2229}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":-0.0102},{"period":"3month","weight":0.0276},{"period":"6month","weight":-0.0041},{"period":"1year","weight":0.0236},{"period":"ytd","weight":0.0008}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"Euroeyes International Eye Clinic Ltd是一家总部位于德国的眼科视光学公司。该公司提供各种视力矫正服务，例如屈光激光手术、有晶状体眼手术、晶状体植入和晶状体置换手术。该公司的业务遍及德国、丹麦、英国和中国。","yearOnYearQuotes":[{"month":1,"riseRate":0.142857,"avgChangeRate":-0.055818},{"month":2,"riseRate":0.428571,"avgChangeRate":0.001865},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.089545},{"month":4,"riseRate":0.428571,"avgChangeRate":0.062935},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.016393},{"month":6,"riseRate":0.571429,"avgChangeRate":0.005388},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.000504},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.019977},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.05226},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.022059},{"month":11,"riseRate":0.428571,"avgChangeRate":0.039908},{"month":12,"riseRate":0.428571,"avgChangeRate":0.041262}],"exchange":"SEHK","name":"德视佳","nameEN":"EUROEYES"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"德视佳(01846)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供德视佳(01846)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"德视佳,01846,德视佳股票,德视佳股票老虎,德视佳股票老虎国际,德视佳行情,德视佳股票行情,德视佳股价,德视佳股市,德视佳股票价格,德视佳股票交易,德视佳股票购买,德视佳股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"德视佳(01846)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供德视佳(01846)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}